Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): From the results of phase I and phase II clinical trials

Akihiro Tanimoto, Masumi Kadoya, Yasutaka Kawamura, Ryohei Kuwatsuru, Takehiko Gokan, Shinji Hirohashi

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): From the results of phase I and phase II clinical trials'. Together they form a unique fingerprint.